Version history / source ledger
Each update replaces the current ledger and keeps the previous one public. This page lists every version, what changed between them and the cohort exactly as it was first published, so a figure quoted from an earlier reading can still be traced
First published on this site in October 2026. The ledger itself was first released in September 2026; version dates are the months the data was collected
01 / versions
Counts are issuers and SEC filing records in that version. Downloads are the files as released; older versions are not edited after release
| Version | Collected | Data through | Issuers | Filings | Quarters | Download |
|---|---|---|---|---|---|---|
| 1.1.0 Current | October 2026 | 1 Oct 2026 | 39 | 410 | 5 complete | CSV 1.1.0 · JSON 1.1.0 |
| 1.0.0 | September 2026 | 22 Sep 2026 | 38 | 403 | 4 complete, 1 partial | CSV 1.0.0 · JSON 1.0.0 |
02 / what changed
Computed by comparing the two ledgers record by record, so a list that says nothing changed means no field changed
03 / as first published
Kept as released. Quarters marked partial then were still open when that version was built
| Priced | Issuer | Sector | Quarter | Source |
|---|---|---|---|---|
| CapsoVision, IncCIK 1378325 | Medical device and diagnostics | Q3 2025 | 424B4 ↗ | |
| CARLSMED, INC.CIK 1794546 | Medical device and diagnostics | Q3 2025 | 424B4 ↗ | |
| SHOULDER INNOVATIONS, INC.CIK 1699350 | Medical device and diagnostics | Q3 2025 | 424B4 ↗ | |
| Heartflow, Inc.CIK 1464521 | Medical device and diagnostics | Q3 2025 | 424B4 ↗ | |
| Curanex Pharmaceuticals IncCIK 2025942 | Biotech and pharma | Q3 2025 | 424B4 ↗ | |
| Picard Medical, Inc.CIK 2030617 | Medical device and diagnostics | Q3 2025 | 424B4 ↗ | |
| LB PHARMACEUTICALS INCCIK 1691082 | Biotech and pharma | Q3 2025 | 424B4 ↗ | |
| BillionToOne, Inc.CIK 2070849 | Medical device and diagnostics | Q4 2025 | 424B4 ↗ | |
| Evommune, Inc.CIK 2044725 | Biotech and pharma | Q4 2025 | 424B4 ↗ | |
| Park Dental Partners, Inc.CIK 2069604 | Healthcare services | Q4 2025 | 424B4 ↗ | |
| Lumexa Imaging Holdings, Inc.CIK 2071288 | Healthcare services | Q4 2025 | 424B4 ↗ | |
| Medline Inc.CIK 2046386 | Medical device and diagnostics | Q4 2025 | 424B4 ↗ | |
| Aktis Oncology, Inc.CIK 2035832 | Biotech and pharma | Q1 2026 | 424B4 ↗ | |
| Polaryx Therapeutics, Inc.CIK 2075320 | Biotech and pharma | Q1 2026 | 424B4 ↗ | |
| Veradermics, IncCIK 1827635 | Biotech and pharma | Q1 2026 | 424B4 ↗ | |
| Eikon Therapeutics, Inc.CIK 1861123 | Biotech and pharma | Q1 2026 | 424B4 ↗ | |
| SpyGlass Pharma, Inc.CIK 1778922 | Biotech and pharma | Q1 2026 | 424B4 ↗ | |
| Generate Biomedicines, Inc.CIK 2100782 | Biotech and pharma | Q1 2026 | 424B4 ↗ | |
| MiniMed Group, Inc.CIK 2062583 | Medical device and diagnostics | Q1 2026 | 424B4 ↗ | |
| Alamar Biosciences, Inc.CIK 2104204 | Medical device and diagnostics | Q2 2026 | 424B4 ↗ | |
| Kailera Therapeutics, Inc.CIK 2096997 | Biotech and pharma | Q2 2026 | 424B4 ↗ | |
| Lakewood-Amedex Biotherapeutics Inc.CIK 2079272 | Biotech and pharma | Q2 2026 | 424B4 ↗ | |
| Avalyn Pharma Inc.CIK 1540171 | Biotech and pharma | Q2 2026 | 424B4 ↗ | |
| Hemab Therapeutics Holdings, Inc.CIK 2114044 | Biotech and pharma | Q2 2026 | 424B4 ↗ | |
| Seaport Therapeutics, Inc.CIK 2042347 | Biotech and pharma | Q2 2026 | 424B4 ↗ | |
| Mobia Medical, Inc.CIK 1489993 | Medical device and diagnostics | Q2 2026 | 424B4 ↗ | |
| Odyssey Therapeutics, Inc.CIK 1882782 | Biotech and pharma | Q2 2026 | 424B4 ↗ | |
| Conexeu Sciences Inc.CIK 2066836 | Medical device and diagnostics | Q2 2026 | 424B4 ↗ | |
| Parabilis Medicines, Inc.CIK 1657677 | Biotech and pharma | Q2 2026 | 424B4 ↗ | |
| Kardigan, Inc.CIK 2123613 | Biotech and pharma | Q2 2026 | 424B4 ↗ | |
| Scribe Therapeutics, Inc.CIK 1853921 | Biotech and pharma | Q3 2026 (partial then) | 424B4 ↗ | |
| Apnimed, Inc.CIK 1745648 | Biotech and pharma | Q3 2026 (partial then) | 424B4 ↗ | |
| Attovia Therapeutics, Inc.CIK 2058707 | Biotech and pharma | Q3 2026 (partial then) | 424B4 ↗ | |
| Braveheart Bio, Inc.CIK 2131524 | Biotech and pharma | Q3 2026 (partial then) | 424B4 ↗ | |
| BlossomHill Therapeutics, Inc.CIK 1839970 | Biotech and pharma | Q3 2026 (partial then) | 424B4 ↗ | |
| Latigo Biotherapeutics, Inc.CIK 2056611 | Biotech and pharma | Q3 2026 (partial then) | 424B4 ↗ | |
| Vogenx, Inc.CIK 1903784 | Biotech and pharma | Q3 2026 (partial then) | 424B4 ↗ | |
| Electra Therapeutics, Inc.CIK 2088082 | Biotech and pharma | Q3 2026 (partial then) | 424B4 ↗ |